Altus Diagnostic Profile
Key Indicators
- Authorised Capital ₹ 0.80 M
- Paid Up Capital ₹ 0.80 M
- Company Age 11 Year, 9 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.20 M
- Revenue Growth 2.58%
- Profit Growth 7.27%
- Ebitda -5.06%
- Net Worth 17.44%
- Total Assets -7.12%
About Altus Diagnostic
Altus Diagnostic Private Limited (ADPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 May 2013 and has a history of 11 years and nine months. Its registered office is in Chandigarh, Chandigarh.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.80 M and a paid-up capital of Rs 0.80 M.
The company currently has active open charges totaling ₹7.20 M.
Alok Kumar and Ashok Kumar serve as directors at the Company.
Company Details
- Location Chandigarh, Chandigarh
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U85100CH2013PTC034481
-
Company No.
034481
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
10 May 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Altus Diagnostic?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Alok Kumar
|
Director | 10-May-2013 | Current |
|
Ashok Kumar
|
Director | 22-Jul-2016 | Current |
Financial Performance of Altus Diagnostic.
Altus Diagnostic Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 2.58% increase. The company also saw a slight improvement in profitability, with a 7.27% increase in profit. The company's net worth Soared by an impressive increase of 17.44%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Altus Diagnostic?
In 2017, Altus Diagnostic had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.20 M
₹0
Charges Breakdown by Lending Institutions
- State Bank Of India : 0.49 Cr
- Others : 0.23 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 08 Aug 2024 | Others | ₹1.50 M | Open |
| 22 Jul 2016 | Others | ₹0.80 M | Open |
| 25 Jun 2013 | State Bank Of India | ₹2.90 M | Open |
| 25 Jun 2013 | State Bank Of India | ₹2.00 M | Open |
How Many Employees Work at Altus Diagnostic?
Unlock and access historical data on people associated with Altus Diagnostic, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Altus Diagnostic, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Altus Diagnostic's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
